BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7512469)

  • 1. Lipid profile during antihypertensive treatment. The SLIP Study Group. Study on Lipids with Isoptin Press.
    Libretti A; Catalano M
    Drugs; 1993; 46 Suppl 2():16-23. PubMed ID: 7512469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic effect of two hormonal preparations in postmenopausal women.
    Bissonnette F; Lussier-Cacan S; Fugère P; Bérubé S
    Maturitas; 1997 Jul; 27(3):275-84. PubMed ID: 9288700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia.
    Ellen RL; McPherson R
    Am J Cardiol; 1998 Feb; 81(4A):60B-65B. PubMed ID: 9526816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group.
    Grimm RH; Flack JM; Grandits GA; Elmer PJ; Neaton JD; Cutler JA; Lewis C; McDonald R; Schoenberger J; Stamler J
    JAMA; 1996 May 22-29; 275(20):1549-56. PubMed ID: 8622245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in serum lipoprotein(a) and lipids during treatment of hyperthyroidism.
    Kung AW; Pang RW; Lauder I; Lam KS; Janus ED
    Clin Chem; 1995 Feb; 41(2):226-31. PubMed ID: 7874776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum cholestanol, cholesterol precursors, and plant sterols during placebo-controlled treatment of primary biliary cirrhosis with ursodeoxycholic acid or colchicine.
    Miettinen TA; Färkkilä M; Vuoristo M; Karvonen AL; Leino R; Lehtola J; Friman C; Seppälä K; Tuominen J
    Hepatology; 1995 May; 21(5):1261-8. PubMed ID: 7737632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-density lipoprotein and apolipoprotein A-I deficiency induced by combination therapy with probucol and bezafibrate.
    Saku K; Zhang B; Jimi S; Bai H; Hirata K; Sasaki N; Liu R; Arakawa K
    Eur J Clin Pharmacol; 1995; 48(3-4):209-15. PubMed ID: 7589043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A brief review paper of the efficacy and safety of atorvastatin in early clinical trials.
    Bakker-Arkema RG; Best J; Fayyad R; Heinonen TM; Marais AD; Nawrocki JW; Black DM
    Atherosclerosis; 1997 May; 131(1):17-23. PubMed ID: 9180240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microangiopathic hemolytic anemia complicating FK506 (tacrolimus) therapy.
    Mach-Pascual S; Samii K; Beris P
    Am J Hematol; 1996 Aug; 52(4):310-2. PubMed ID: 8701950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta.
    Glorieux FH; Bishop NJ; Plotkin H; Chabot G; Lanoue G; Travers R
    N Engl J Med; 1998 Oct; 339(14):947-52. PubMed ID: 9753709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-protease inhibitors.
    Flexner C
    N Engl J Med; 1998 Apr; 338(18):1281-92. PubMed ID: 9562584
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie.
    Negrier S; Escudier B; Lasset C; Douillard JY; Savary J; Chevreau C; Ravaud A; Mercatello A; Peny J; Mousseau M; Philip T; Tursz T
    N Engl J Med; 1998 Apr; 338(18):1272-8. PubMed ID: 9562581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse effects of class I antiarrhythmic drugs.
    Caron J; Libersa C
    Drug Saf; 1997 Jul; 17(1):8-36. PubMed ID: 9258628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatotoxicity of clozapine.
    Hummer M; Kurz M; Kurzthaler I; Oberbauer H; Miller C; Fleischhacker WW
    J Clin Psychopharmacol; 1997 Aug; 17(4):314-7. PubMed ID: 9241012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team.
    Englund JA; Baker CJ; Raskino C; McKinney RE; Petrie B; Fowler MG; Pearson D; Gershon A; McSherry GD; Abrams EJ; Schliozberg J; Sullivan JL
    N Engl J Med; 1997 Jun; 336(24):1704-12. PubMed ID: 9182213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative liver function in patients with rheumatoid arthritis treated with low-dose methotrexate: a longitudinal study.
    Beyeler C; Reichen J; Thomann SR; Lauterburg BH; Gerber NJ
    Br J Rheumatol; 1997 Mar; 36(3):338-44. PubMed ID: 9133966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): a double-blind comparison with glibenclamide.
    Draeger KE; Wernicke-Panten K; Lomp HJ; Schüler E; Rosskamp R
    Horm Metab Res; 1996 Sep; 28(9):419-25. PubMed ID: 8911976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hydrochlorothiazide and captopril on lipoprotein lipid composition in patients with essential hypertension.
    Bagdade JD; Buchanan WF; Pollare T; Lithell H
    Eur J Clin Pharmacol; 1996; 49(5):355-9. PubMed ID: 8866628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatotoxicity due to antituberculosis therapy. Clinical profile and reintroduction of therapy.
    Singh J; Garg PK; Tandon RK
    J Clin Gastroenterol; 1996 Apr; 22(3):211-4. PubMed ID: 8724260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipyrone interference on several common biochemical tests.
    Gascón N; Otal C; Martínez-Brú C; Mercé J; Cortés M; Arcelus R; Queraltó JM; Sánchez JM; González-Sastre F
    Clin Chem; 1993 Jun; 39(6):1033-6. PubMed ID: 8504533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.